Company Overview - Aibo Medical closed at 81.07 yuan, up 1.58%, with a rolling PE ratio of 40.65 times and a total market value of 15.366 billion yuan [1] - The company ranks 83rd in the medical device industry, which has an average PE ratio of 49.02 times and a median of 36.25 times [1] Shareholder Information - As of March 31, 2025, Aibo Medical had 9,729 shareholders, a decrease of 94 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Business Operations - Aibo Medical focuses on the independent research, production, sales, and related services of ophthalmic medical devices, with main products including artificial lenses, surgical products, orthokeratology lenses, myopia control products, contact lenses, and other vision care products [1] Financial Performance - In the first quarter of 2025, Aibo Medical reported revenue of 357 million yuan, a year-on-year increase of 15.07%, and a net profit of 92.5581 million yuan, a year-on-year decrease of 10.05%, with a gross profit margin of 64.60% [1]

5月7日，佰仁医疗今日收盘112.35元，上涨1.33%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到90.53倍，总市值154.36亿元。 北京佰仁医疗科技股份有限公司是国内技术领先的、专注于动物源性植介入医疗器械研发与生产的高新 技术企业,主要产品主要包括心脏瓣膜置换与修复、先天性心脏病植介入治疗、外科软组织修复等。 最新一期业绩显示，2025年一季报，公司实现营业收入1.00亿元，同比31.30%；净利润3250.43万元， 同比290.69%，销售毛利率85.72%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)104佰仁医疗90.53105.4911.99154.36亿行业平均 49.0247.364.56104.18亿行业中值36.2537.322.4146.91亿1天益医疗-1703.20-2917.401.8221.70亿2澳华内 镜-638.65320.325.1267.31亿3诺唯赞-417.24-493.492.2989.29亿4爱朋医疗-335.34254.764.0427.52亿5博晖 创新-330.17523.933.5248.44亿6硕世生物-127.7 ...

5月7日，咸亨国际今日收盘14.67元，上涨1.17%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到25.54倍，创33天以来新低，总市值60.20亿元。 咸亨国际科技股份有限公司的主营业务是工器具、仪器仪表等类产品的MRO集约化，并从事上述产品 研发、生产、销售及相关技术服务。公司的主要产品是工具、仪器、服务。 最新一期业绩显示，2025年一季报，公司实现营业收入6.40亿元，同比46.04%；净利润2157.17万元， 同比144.43%，销售毛利率21.46%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)28咸亨国际25.5427.003.4960.20亿行业平均 81.1784.974.4747.03亿行业中值51.7256.133.0533.62亿1思林杰-33914.48164.872.0025.18亿2蓝盾光 电-944.41717.372.3246.52亿3精测电子-401.07-181.124.97176.77亿4恒合股份-175.25-158.625.8415.40亿5 禾信仪器-154.35-127.6615.6258.71亿6莱赛激光-147.08-185. ...

Group 1 - Qingdao Port's stock closed at 8.86 yuan, up 2.19%, with a rolling PE ratio of 10.81, marking a new low in 12 days and a total market value of 57.511 billion yuan [1] - The average PE ratio for the shipping and port industry is 13.31, with a median of 14.58, placing Qingdao Port in 8th position within the industry [1] - As of the first quarter of 2025, 31 institutions hold shares in Qingdao Port, including 22 funds, with a total holding of 492,844.41 million shares valued at 48.397 billion yuan [1] Group 2 - Qingdao Port International Co., Ltd. specializes in the loading and unloading of various goods, including containers, metal ores, coal, and crude oil, along with logistics and port value-added services [2] - The company achieved a revenue of 4.807 billion yuan in the first quarter of 2025, representing a year-on-year increase of 8.51%, and a net profit of 1.402 billion yuan, up 6.51%, with a gross profit margin of 38.57% [2] - Qingdao Port has received numerous national honors, including being recognized as one of the five exemplary benchmarks of world-class ports by the Ministry of Transport [2]

Group 1 - The core viewpoint of the article highlights that 科锐国际 (Core International) is experiencing a decline in stock price and has a relatively low PE ratio compared to its industry peers [1] - As of May 7, the stock price of 科锐国际 closed at 32.1 yuan, down 3.81%, with a rolling PE ratio of 28.40 times and a total market capitalization of 6.317 billion yuan [1] - The average PE ratio for the professional services industry is 56.67 times, with a median of 36.27 times, placing 科锐国际 at the 18th position in the industry ranking [1] Group 2 - In terms of capital flow, on May 7, there was a net outflow of 18.8873 million yuan from 科锐国际, with a total outflow of 11.9428 million yuan over the past five days [1] - The latest quarterly report for Q1 2025 shows that 科锐国际 achieved an operating revenue of 3.303 billion yuan, a year-on-year increase of 25.13%, and a net profit of 57.7839 million yuan, up 42.15% year-on-year, with a gross profit margin of 5.52% [1]

Group 1 - The core viewpoint of the article highlights Chengdu Xian Dao's current stock performance, with a closing price of 15.82 yuan, an increase of 1.54%, and a rolling PE ratio of 96.48, marking a new low in 20 days, with a total market value of 6.339 billion yuan [1] - Chengdu Xian Dao ranks 40th in the medical services industry based on PE ratio, which has an average of 38.66 and a median of 38.36 [1] - As of March 31, 2025, the number of shareholders for Chengdu Xian Dao has increased to 16,254, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - The main business of Chengdu Xian Dao includes drug early discovery and development services related to DEL technology, offering services such as DEL screening, DEL library customization, FBDD/SBDD, custom drug development, compound structure intellectual property transfer, and chemical synthesis [1] - In the latest quarterly report for Q1 2025, the company achieved an operating income of 107 million yuan, a year-on-year decrease of 0.60%, while net profit reached 28.2844 million yuan, a year-on-year increase of 102.90%, with a gross profit margin of 51.87% [1]

Group 1 - The core viewpoint of the articles highlights that Chunli Medical's stock price has increased by 4.03% to 15.76 yuan, with a rolling PE ratio of 47.28, marking a new low in 140 days, and a total market capitalization of 6.045 billion yuan [1][2] - Chunli Medical ranks 87th in the medical device industry based on PE ratio, with the industry average at 48.90 and the median at 36.41 [1][2] - As of the first quarter of 2025, 13 institutions hold shares in Chunli Medical, including 8 funds, with a total holding of 31.6307 million shares valued at 429 million yuan [1] Group 2 - Chunli Medical specializes in the research, production, and sales of implantable orthopedic medical devices, with key products including spinal, trauma, joint, sports medicine implants, and surgical instruments [1] - The company achieved a revenue of 230 million yuan in the first quarter of 2025, reflecting a year-on-year growth of 3.60%, and a net profit of 58.0711 million yuan, with a year-on-year increase of 5.20% and a gross margin of 66.69% [1]

大叶股份（300879）发布异动公告，截至2025年5月6日，公司滚动市盈率为41.85倍，静态市盈率为 428.03倍，市净率为4.93倍；根据中证指数有限公司发布数据，公司所属中上协行业分类"专用设备制造 业"最新的滚动市盈率为27.7倍，静态市盈率为28.05倍，市净率为2.85倍，公司当前滚动市盈率、静态 市盈率、市净率严重偏离同行业上市公司合理估值，郑重提醒广大投资者理性投资，注意投资风险。 ...

Group 1 - The core viewpoint of the articles highlights that Lepu Medical's stock closed at 11.41 yuan, with a PE ratio of 149.42, marking a new low in 20 days, and a total market capitalization of 21.458 billion yuan [1] - The average PE ratio for the medical device industry is 48.90, with a median of 36.41, positioning Lepu Medical at the 111th rank within the industry [1] - As of March 31, 2025, Lepu Medical has 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Lepu Medical's main business includes medical devices, pharmaceuticals, medical services, and health management, with its primary products being in these categories [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44%, with a gross profit margin of 64.03% [1] - The PE ratios for Lepu Medical are significantly higher than the industry averages, indicating potential overvaluation compared to peers [2]

5月6日，物产金轮今日收盘14.37元，上涨2.50%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到19.15倍，创20天以来新低，总市值29.69亿元。 从行业市盈率排名来看，公司所处的纺织服装行业市盈率平均27.45倍，行业中值21.41倍，物产金轮排 名第58位。 截至2025年一季报，共有8家机构持仓物产金轮，其中其他4家、基金4家，合计持股数9599.44万股，持 股市值14.14亿元。 物产中大金轮蓝海股份有限公司的主营业务是纺织梳理器材、不锈钢装饰材料领域的研发、生产和销售 以及特种钢丝和装备制造。公司的主要产品是纺织梳理器材、不锈钢装饰板、特种钢丝、装备制造。公 司是最早从事纺织梳理器材生产与销售的企业之一。"金轮"品牌拥有较高的市场认知度，"金轮"商标评 定为江苏省著名商标，"金轮"品牌已经成为行业的著名品牌，客户对"金轮"品牌梳理器材的认同度较 高。 最新一期业绩显示，2025年一季报，公司实现营业收入5.25亿元，同比-15.95%；净利润3191.66万元， 同比-7.43%，销售毛利率18.87%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)58物产金轮1 ...